The anti-apoptotic gene MCL1 was chosen as it is dysregulated in numerous tumor entities32 and MCL1 inhibitors are currently investigated in clinical trials yielding mixed results33 (NCT03218683). The gene discussed is MCL1; the disease is neoplasm.